Facebook
Twitter
LinkedIn
Forward
0299_SHVGR_Perinatal Opioid Use Disorder_EM
Description:
Managing perinatal opioid use disorder is critically important for both maternal and infant health. If left untreated, opioid use disorder during pregnancy can lead to a range of adverse outcomes, including preterm birth, low birth weight, neonatal abstinence syndrome, and even maternal overdose or death. Proper management, including medication-assisted treatment, helps reduce the risk of these complications by stabilizing the mother's opioid use and supporting her overall health. Effective management not only improves the chances of a healthier pregnancy but also minimizes the risk of withdrawal symptoms in newborns and supports better long-term developmental outcomes for the child.
Target Audience
Nurse Practitioner (NP)
Nurse, Registered (RN)
Pharmacists (PharmD)
Physicians (MD or DO)
Physician Assistant (PA)
Psychologists
Social Workers
Other Healthcare Professionals
Learning Objectives
By the end of this activity, learners will be able to:
1.) Consider stigma and bias's impact on care for perinatal patients with opioid use disorder.
2.) Practice counseling pregnant patients about agonist medications for opioid use disorder.
3.) Describe at least three options for initiating medications for opioid use disorder.
4.) Examine acute labor pain management for patients on chronic agonist treatment.
Assembly Bills 1195 & 241- Culturally Appropriate Care which is Free of Implicit Biases:
Crawford, A. D., McGlothen-Bell, K., Recto, P., McGrath, J. M., Scott, L., Brownell, E. A., & Cleveland, L. M. (2022). Stigmatization of pregnant individuals with opioid use disorder. Women's Health Reports, 3(1), 172-179.
Kantrowitz-Gordon, I., Price, C., Rudolf, V., Downey, G., & Castagnola, K. (2022). Exploring perinatal nursing care for opioid use disorder: knowledge, stigma, and compassion. The Journal of perinatal & neonatal nursing, 36(4), 353-361.
Azuine, R. E., Ji, Y., Chang, H. Y., Kim, Y., Ji, H., DiBari, J., ... & Wang, X. (2019). Prenatal risk factors and perinatal and postnatal outcomes associated with maternal opioid exposure in an urban, low-income, multiethnic US population. JAMA network open, 2(6), e196405-e196405.
Blebu, B., Jackson, A., Reina, A., Dossett, E. C., & Saleeby, E. (2024). Social Determinants Among Pregnant Clients With Perinatal Depression, Anxiety, Or Serious Mental Illness: Study examines co-occurring social determinants of health for people experiencing perinatal mood and anxiety disorders or serious mental illness. Health Affairs, 43(4), 532-539.
Disclosure of Financial or In-Kind Commercial Support & Conflict of Interest
Gnanagurudasan Prakasam, MD, a planning team member for this activity, receives consultant fees from Novo Nordisk (related to growth hormones), Medtronic (related to insulin pumps), Dexcom (related to glucose sensors), Mannkind (related to inhaled insulin), Alexion (related to HPP), and K Kirin (related to XLH) as well as speaker fees from Lilly (related to diabetes), Sanozi (related to Diabetes Type 1 prevention), and Abbvie (related to puberty). These ineligible relationships were deemed not relevant to this activity’s topic, and thus mitigation was not needed.
Sophia Humphreys, PharmD, a planning team member for this activity has recently ended financial relationships with the following ineligible companies: Pharmacosmos (ended 12/2023), Fresenius Kabi (ended 10/2022), and Heron (ended 10/2022).
No one else involved in the planning or presentation of this educational activity have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. No financial or in-kind commercial support was received to produce or promote this educational activity.
Additional faculty involved the planning of this learning activity are as follows:
Carolin Delker, NP
Max Ingersoll, FNP-BC, MSN
Jill Kacher Cobb, MD
Tam Nguyen, MD
Lori Petrini
Michelle Mah
Luanne Ridgley, LSW
Christopher Mack
– Provider Designee/Verification: Kerri Maya, PhD(c), MSL, RN, NPD-BC
Erin Lund, MD, MPH
Erin Lund, MD, MPH
Accreditation
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
Credit Designation Statement
Sutter Health designates this Enduring Materials activity for a maximum of 1.75 AMA PRA Category 1 Credits™ for physicians, 1.75 continuing professional development contact hours for nurses, 1.75 knowledge-based contact hours for pharmacists, and 1.75 approved continuing education hours for social workers. Learners should claim only the credit commensurate with the extent of their participation in the activity.
Note to Other Disciplines: AMA PRA Category 1 Credits HOURS™ Continuing Medical Education is acceptable for meeting the continuing education requirements for Pharmacists, Physician Assistants, Psychologists, Registered Nurses, and Respiratory Care Practitioners. For other disciplines, please check with the regulatory board for your discipline to confirm what type of credits meet the continuing education requirements. Continuing education hours for nurses accredited by ANCC, via Joint Accreditation.
Available Credit
- 1.75 ACPE
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health designates this Enduring activity for a maximum of 1.75 of ACPE credit(s). Credits for pharmacists and technicians will be transmitted to CPE Monitor and will be available within 60 days post-activity pending submission of individual NABP e-PID and DOB (mm/dd only). Learners should claim only the credit commensurate with the extent of their participation in the activity.
- 1.75 AMA PRA Category 1 Credit™
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health designates this Enduring activity for a maximum of 1.75 AMA PRA Category 1 Credit™ for physicians. Learners should claim only the credit commensurate with the extent of their participation in the activity.
- 1.75 AMA PRA Category 1 Credit™ Hour(s)
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Sutter Health certifies this Enduring activity was designated for a maximum of 1.75 AMA PRA Category 1 Credit™ Hour(s). Non-physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.75 ANCC
In support of improving patient care, Sutter Health, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
This course/program has been awarded 1.75 ANCC contact hour(s). Sutter Health is accredited provider of nursing continuing professional development. Learners should claim only the credit commensurate with the extent of their participation in the activity.
- 1.75 ASWB-ACE
As a Jointly Accredited Organization, Sutter Health is approved to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Organizations, not individual courses, are approved under this program. Regulatory boards are the final authority on courses accepted for continuing education credit. Social workers completing this course receive 1.75 continuing education credits.
- 1.75 CA BRN
This activity is approved for 1.75 contact hour(s) by Sutter Health, which is an approved provider by the California Board of Registered Nursing. (Provider Number 17182). Learners should claim only the credit commensurate with the extent of their participation in the activity.
- 1.75 IPCE
This activity was planned by and for the healthcare team, and learners will receive 1.75 Interprofessional Continuing Education (IPCE) credit for learning and change.
